O60911 (CATL2_HUMAN) Homo sapiens (Human)

Cathepsin L2 UniProtKBAFDB90v4InterProSTRINGInteractive Modelling

334 aa; Sequence (Fasta)

Available Structures

25 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Tick salivary cystatin Ricistatin in complex with cathepsin V
7pk4
 Heteromer
A0A0K8RMA7; 		113-334
1×GOL; 6×EDO; 1×PEG;
Assess
Unreduced cathepsin V in complex with stefin A
3kfq
 Heteromer
P01040; 		114-334
Assess
Structure of clitocypin - cathepsin V complex
3h6s
 Heteromer
Q3Y9I6; 		114-334
1×SO4;
Assess
Peptide GAKSAA in complex with human cathepsin V C25A mutant
7qo2
homo-2-mer113-334
5×MPD; 3×CL; 3×GOL; 1×TFA;
Assess
Sulfonated Calpeptin is a promising drug candidate against SARS-CoV-2 infections
7qgw
homo-2-mer114-334
6×CL; 5×MPD; 6×GOL; 2×RN2;
Assess
Peptide VACKSSQP in complex with human cathepsin V C25A mutant
7qff
homo-2-mer114-334
6×MPD; 2×CL; 4×GOL; 1×TFA;
Assess
Peptide AYFKKVL in complex with human cathepsin V C25A mutant
7qfh
homo-2-mer114-334
9×MPD; 2×CL; 6×GOL; 1×TFA; 2×NH2;
Assess
Peptide EVCKKKK in complex with human cathepsin V C25A mutant
7q8h
homo-2-mer114-334
5×MPD; 1×CL; 2×GOL; 4×TFA;
Assess
Peptide VYEKKP in complex with human cathepsin V C25S mutant
7qns
monomer113-334
2×CL; 1×GOL; 2×TFA; 1×MPD;
Assess
Peptide KPKKKTK in complex with human cathepsin V C25A mutant
7q8m
monomer113-334
2×MPD; 1×GOL; 4×TFA;
Assess
Peptide AVAEKQ in complex with human cathepsin V C25S mutant
7q8i
monomer113-334
2×CL; 3×MPD;
Assess
Peptide IILKEK in complex with human cathepsin V C25S mutant
7q8j
monomer113-334
2×GOL;
Assess
Peptide LLKVAL in complex with human cathepsin V C25S mutant
7q8p
monomer113-334
1×CL; 2×MPD; 1×GOL;
Assess
Peptide VPCGTAHE in complex with human cathepsin V C25A mutant
7q8l
monomer113-334
2×MPD; 1×CL; 2×GOL;
Assess
Peptide KKYDAFLA in complex with human cathepsin V C25A mutant
7q8n
monomer113-334
1×CL; 2×MPD;
Assess
Peptide ALAASS in complex with human cathepsin V C25S mutant
7q8g
monomer113-334
1×CL; 1×MPD;
Assess
Peptide GAKSAA in complex with human cathepsin V C25A mutant
7qhj
monomer114-334
4×MPD; 7×GOL; 4×CL; 1×NA;
Assess
Peptide LLKAVAEKQ in complex with human cathepsin V C25A mutant
7q9h
monomer114-334
3×CL; 3×MPD; 2×GOL;
Assess
Peptide GNYKEAKK in complex with human cathepsin V C25A mutant
7q8f
monomer114-334
4×MPD; 1×CL; 1×TFA; 2×GOL;
Assess
CRYSTAL STRUCTURE OF HUMAN CATHEPSIN V COMPLEXED WITH AN IRREVERSIBLE VINYL SULFONE INHIBITOR
1fh0
monomer114-334
1×0IW; 1×SO4;
Assess
Peptide LLKVAL in complex with human cathepsin V C25S mutant
7q8k
monomer114-334
3×MPD; 2×GOL;
Assess
Peptide TRESEDLE in complex with human cathepsin V C25A mutant
7q8d
monomer114-334
3×MPD; 2×CL; 2×GOL;
Assess
Peptide QLRQQE in complex with human cathepsin V C25A mutant
7qhk
monomer114-334
2×CL; 1×MPD; 1×GOL; 1×TFA;
Assess
Peptide LLSGKE in complex with human cathepsin V C25S mutant
7q8o
monomer114-334
2×CL; 1×MPD;
Assess
Peptide RLSAKP in complex with human cathepsin V C25S mutant
7q8q
monomer114-334
2×MPD; 1×CL;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6jd0.1.Amonomer0.8621-334
2×POL;77.32
Assess